"INO has had a number of successes clinically and marquee collaborations that have led to its market cap being what it is today." (5/20/15) Inovio Pharmaceuticals Inc. - The Life Sciences Report Interview with Ross Silver More >
"Subsequent analysis of CANF's CF101 data shows promise in a certain subset of patients." (5/13/15) Can-Fite BioPharma Ltd. - The Life Sciences Report 2015 Small-Cap Biotech Watchlist Update with Reni Benjamin More >
Subscribe to Streetwise Reports’ Newsletters
Receive weekly insight into today’s investment ideas from leading analysts and experts.
To make sure our emails arrive in your inbox, please add firstname.lastname@example.org to your "safe sender" list. If you are unsure how to whitelist or add someone to your safe senders list, please follow the instructions here.
"We view Omidria sales as a means for OMER to fund one of the most exciting biotechnology pipelines in the industry." (4/8/15) Omeros Corp. - The Life Sciences Report Interview with Jason Kolbert More >